Since 2010, the
incidence of
severe fever with thrombocytopenia syndrome (SFTS) has been increased. Owing the progress in
diagnosis and
treatment, the overall
mortality of SFTS in
China has decreased, while the
mortality in critical SFTS
patients is still high. In order to provide guidance and working
procedures for clinicians to
diagnose and treat critical SFTS, the National Medical Center for Major
Public Health Events invited experts to discuss and formulate this
consensus based on their experience and up-to-date
knowledge on SFTS.